This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Genomic Health, Inc.. Active years: 2023-2026.
Company Filing History:
Years Active: 2023-2026
Title: The Innovations of Phillip Febbo
Introduction
Phillip Febbo is a notable inventor based in Mill Valley, California. He has made significant contributions to the field of cancer research, particularly in bladder cancer surveillance. His innovative methods have the potential to improve patient outcomes and enhance monitoring techniques.
Latest Patents
Phillip Febbo holds a patent for "DNA methylation and mutational analysis methods for bladder cancer surveillance." This patent outlines methods for monitoring bladder cancer patients and analyzing patient samples for the presence of methylated DNA and specific gene mutations. The analysis results can be correlated with clinical outcome measures, such as the risk of bladder cancer recurrence.
Career Highlights
Phillip is currently associated with Genomic Health, Inc., where he applies his expertise in genomic analysis to advance cancer diagnostics. His work focuses on developing innovative solutions that can lead to better patient management and treatment strategies.
Collaborations
Phillip has collaborated with notable colleagues, including Margarita Lopatin and Athanasios Tsiatis. These partnerships have fostered a collaborative environment that enhances research and development in the field of cancer surveillance.
Conclusion
Phillip Febbo's contributions to bladder cancer surveillance through his patented methods exemplify the importance of innovation in healthcare. His work continues to pave the way for advancements in cancer monitoring and patient care.